Barr Pharmaceuticals has agreed to pay $5.9 million to settle a lawsuit alleging that Barr accepted $20 million from Warner Chilcott for agreeing to not sell a generic version of Warner’s oral contraceptive Ovcon for five years, the Wall Street Journal reports.